The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSE.L Regulatory News (LSE)

  • There is currently no data for LSE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LSEG plc Investor Update - 12 June 2017

12 Jun 2017 13:10

RNS Number : 8306H
London Stock Exchange Group PLC
12 June 2017
 

London Stock Exchange Group plc

12 June 2017

 

Contains inside information

 

Investor update event

 

London Stock Exchange Group plc will today host a planned investor update event.

 

The event will provide investors with an overview of the market landscape for Information Services, including FTSE Russell, LCH and Capital Markets. It will show that the Group's global businesses are well positioned in a changing regulatory environment, and will highlight future double-digit growth opportunities and next phase cost efficiencies. Strong revenue growth and continued cost control will deliver further improvement to operating leverage, delivering enhanced operating margins and shareholder value.

The event will be hosted by Xavier Rolet, Chief Executive and David Warren, CFO and feature members of the LSEG Executive Committee and their teams. A copy of the presentation is available on our website: http://www.lseg.com/sites/default/files/content/documents/Regulatory/Investor-relations/2017/June/LSEG_Investor_Relations_Update_Event_12_June_2017.pdf.

Presentations will include the following new information:

 

FTSE Russell

 

· Continued double-digit revenue growth - 2017-2019

 

LCH

 

· Continued double-digit revenue growth in OTC clearing - 2017-2019

· Accelerating EBITDA margin growth - approaching 50% by 2019 (2016: 35.6%)

 

LSEG

 

· Group operating expenses held at c.4% p.a. increase 2017-2019 while the Group continues to develop and deliver revenue growth

· Next phase cost saves of £50m p.a. - by exit 2019

· Group EBITDA margin c.55% by 2019 (2016: 46.5%)

 

Conference call details:

 

To access the Telephone conference call of the event, which starts at 14:00 pm BST:

 

Participant UK FreeCall Dial-In Numbers:

 

United Kingdom

0800 6940257

 

United States

18669669439

 

Participant Std International Dial-In:

+44 (0) 1452 555566

Participant UK LocalCall Dial-In Number:

 

United Kingdom, LocalCall

0844 4933800

 

Further numbers at bottom of this announcement

· Conference ID: 31402457

· We recommend that participants start to dial in 5 minutes prior to ensure a timely start to the conference call.

A replay of the conference call will be available later in the day on our website. A video recording will be made available on our website a few days after the event.

 

For further information:

 

Paul Froud

Gavin Sullivan

Investor Relations

Media

+44 (0)20 7797 3322

+44 (0)20 7797 1222

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGMGMVZZRGNZM
Date   Source Headline
28th Jan 20213:42 pmRNSLSEG All Share Acquisition of Refinitiv - Update
19th Jan 20214:37 pmRNSExpected Completion Date
13th Jan 20211:22 pmRNSLSEG: European Commission Approval
4th Jan 20211:11 pmRNSTotal Voting Rights
14th Dec 20204:47 pmRNSDirector/PDMR Shareholding
11th Dec 20209:54 amRNSDirector/PDMR Shareholding
9th Dec 20201:03 pmRNSPublication of Prospectus and Board Appointments
1st Dec 202010:46 amRNSTotal Voting Rights
25th Nov 202010:38 amRNSDirector/PDMR Shareholding
20th Nov 202010:46 amRNSDirectorate Change
3rd Nov 20203:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202011:25 amRNSResult of Meeting
30th Oct 20203:15 pmRNSUpdate re Circular and General Meeting
23rd Oct 20207:00 amRNSTrading Statement
14th Oct 20201:02 pmRNSNotice of GM
9th Oct 20207:00 amRNSProposed Divestment of Borsa Italiana Group
1st Oct 20209:51 amRNSBlock listing Interim Review
18th Sep 20207:11 amRNSLSEG – Borsa Italiana Group Update)
14th Sep 20201:37 pmRNSDirector/PDMR Shareholding
10th Sep 20209:40 amRNSDirectorate Change
27th Aug 20209:11 amRNSDirector/PDMR Shareholding
21st Aug 20202:14 pmRNSDirector/PDMR Shareholding
3rd Aug 202012:38 pmRNSDirector/PDMR Shareholding
31st Jul 20207:00 amRNSHalf-year Report
31st Jul 20207:00 amRNSLSEG All Share Acquisition of Refinitiv – Update
25th Jun 20207:00 amRNSDirectorate Change
22nd Jun 20204:54 pmRNSStatement Re EC Review of Refinitiv Transaction
22nd Jun 20204:41 pmRNSSecond Price Monitoring Extn
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
3rd Jun 20204:08 pmRNSDirector/PDMR Shareholding
2nd Jun 20209:23 amRNSDirector/PDMR Shareholding
29th Apr 20209:43 amRNSDirector/PDMR Shareholding
22nd Apr 20203:49 pmRNSDirector/PDMR Shareholding
21st Apr 20201:05 pmRNSResult of AGM
21st Apr 202010:36 amRNSAGM Statement
21st Apr 20207:00 amRNSLSEG 2020 Q1 Trading Statement
17th Apr 20209:15 amRNSDirector/PDMR Shareholding
8th Apr 20202:16 pmRNSDirector/PDMR Shareholding
8th Apr 202010:21 amRNSLondon Stock Exchange Group plc AGM Update
1st Apr 20201:18 pmRNSBlock listing Interim Review
1st Apr 20201:13 pmRNSTotal Voting Rights
24th Mar 20204:42 pmRNSSecond Price Monitoring Extn
24th Mar 20204:39 pmRNSPrice Monitoring Extension
23rd Mar 202012:08 pmRNSSecond Price Monitoring Extn
23rd Mar 202012:03 pmRNSPrice Monitoring Extension
20th Mar 20204:47 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202011:09 amRNSDirector/PDMR Shareholding
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.